Danaher to acquire Masimo for $9.9 billion

robot
Abstract generation in progress

Danaher has agreed to acquire Masimo Corp. in an all-cash transaction valued at approximately $9.9 billion, including assumed debt. Danaher will pay $180 per share for the patient monitoring manufacturer, which will operate as a standalone business within Danaher’s diagnostics segment. The deal is expected to contribute significantly to Danaher’s EBITDA and diluted net earnings per share, with closing anticipated in the second half of 2026.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin